CPAP and uvulopalatopharyngoplasty (UPPP) normalized pulmonary hypertension in patients with obstructive sleep apnea (OSAS) Source: Annual Congress 2007 - Sleep apnoea in cardiorespiratory disorders Year: 2007
Effects of CPAP treatment in UARS patients comparing to OSAS patients Source: Annual Congress 2007 - Treatment options in obstructive sleep apnoea Year: 2007
Severe bradyarrhythmias in pts with sleep apnea hypopnea syndrome (OSAHS) and the effect of CPAP treatment. A long-term study with the use of implantable loop recorders Source: Eur Respir J 2003; 22: Suppl. 45, 23s Year: 2003
Effects of CPAP treatment on 6MWD in OSAS and overlap syndrome patients Source: Eur Respir J 2002; 20: Suppl. 38, 294s Year: 2002
Insomnia, OSAS and CPAP treatment Source: Annual Congress 2008 - Clinical aspects of continuous positive airway pressure therapy Year: 2008
The reversibility of hypoxemia in OSA patients is related to CPAP therapy Source: Eur Respir J 2005; 26: Suppl. 49, 112s Year: 2005
AutoCPAP in obstructive sleep apnea (OSA) patients with poor compliance to standard CPAP titration Source: Eur Respir J 2006; 28: Suppl. 50, 409s Year: 2006
Long-term outcome of nCPAP therapy in sleep apnoea patients Source: Eur Respir J 2004; 24: Suppl. 48, 569s Year: 2004
PAI-uPA system in patients with obstructive sleep apnea syndrome (OSAS) in CPAP treatment Source: Annual Congress 2012 - Cardiovascular disease and sleep-disordered breathing Year: 2012
The effect of CPAP in asthma patients with SAHS Source: Virtual Congress 2021 – Home mechanical ventilation: organisation and outcomes Year: 2021
Home automated CPAP titration is as effective as hospital CPAP titration in patients with obstructive sleep apnoea hypopnoea syndrome (OSAHS) Source: Eur Respir J 2004; 24: Suppl. 48, 566s Year: 2004
The effect of theophylline and CPAP on cytokine release in patients with obstructive sleep apnea syndrome (OSAS) Source: Eur Respir J 2006; 28: Suppl. 50, 216s Year: 2006
Compliance with nCPAP in elderly patients with obstructive sleep apnea syndrome (OSAS) Source: Eur Respir J 2004; 24: Suppl. 48, 569s Year: 2004
Long-term cardiovascular outcomes of patients with obstructive sleep apnoea not treated with nasal CPAP Source: Eur Respir J 2002; 20: Suppl. 38, 294s Year: 2002
Predictive factors for stopping use of continuous positive airway pressure (CPAP): an observational cohort of 6938 treated obstructive sleep apnea syndrome (OSAS) patients Source: Annual Congress 2007 - Treatment options in obstructive sleep apnoea Year: 2007
CPAP versus CPAP plus low dose of PDE-inhibitor in men with obstructive sleep apnea-hypopnea syndrome (OSAHS) and erectile dysfunction (ED) Source: Annual Congress 2010 - Clinical aspects of sleep apnoea Year: 2010
Effects of CPAP treatment on physical fitness in patients with obstructive sleep apnoea syndrome (OSAS) Source: Eur Respir J 2003; 22: Suppl. 45, 97s Year: 2003
Comparison of auto-adjusting and fixed positive airway pressure therapy in patients with mild to moderate obstructive sleep apnoea syndrome (OSAS) Source: Eur Respir J 2003; 22: Suppl. 45, 95s Year: 2003
CPAP setting prediction in OSAS patients Source: Annual Congress 2011 - Physiology and diagnostic technology in obstructive sleep apnoea Year: 2011
The effect of CPAP treatment on Galectin-3 level in patients with severe obstructive sleep apnea Source: International Congress 2018 – Cardiovascular and metabolic consequences of sleep-disordered breathing Year: 2018